Poster 45
- Kelley Tangredi
- May 5, 2024
- 1 min read
Updated: Jun 27, 2024
Deucravacitinib in Plaque Psoriasis: Laboratory Parameters Through 4 Years of Treatment in the Phase 3 POETYK PSO-1, PSO-2, and LTE Trials
Authors: Neil J. Korman, Thierry Passeron, Yukari Okubo, Jerry Bagel Richard B. Warren, Lynda Spelman, Kevin Winthrop, Kim Hoyt, Thomas Scharnitz, Subhashis Banerjee, Diamant Thaçi, Mona Shahriari, Linda Stein Gold

Poster 45